Literature DB >> 7780151

Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.

A R Martin1, D D Weisenburger, W C Chan, E I Ruby, J R Anderson, J M Vose, P J Bierman, M A Bast, D T Daley, J O Armitage.   

Abstract

The clinical usefulness of histologic grading in follicular lymphoma (FL) is controversial and is further compromised by the subjective nature and poor reproducibility of most systems in current use. Therefore, we decided to objectively evaluate the importance of cellular proliferation in FL, along with the current grading systems. We studied 106 patients with FL who were uniformly staged and aggressively treated. A proliferative index (PI) was determined quantitatively using an automated image analyzer and a new Ki-67 antibody that stains archival paraffin tissues. The cases were also subclassified according to the Berard, Rappaport, Luke-Collins, and Jaffe methods, and survival analysis was performed. Patients with a low PI (< 40%) had a significantly longer overall survival (OS) than those with a high PI (> or = 40%), but the PI did not predict failure-free survival (FFS). The mean PI correlated well with the subgroups in each of the various classifications. All four of the classification methods were predictive of OS, but only the Berard method appeared to predict FFS and suggest that a proportion of patients with FL may be curable. In multivariate analysis, histologic classification was the only independent predictor of OS (Berard method: relative risk, 3.1) and the International Prognostic Index was the only independent predictor of FFS (relative risk, 2.3). We conclude that the Berard method for grading of FL is clinically useful and, along with the International Prognostic Index, should be included in future clinical studies of FL. The measurement of cellular proliferation does not appear to add additional useful information in FL.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780151

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Primary gastrointestinal follicular center lymphoma resembling multiple lymphomatous polyposis.

Authors:  Y Sakata; R Iwakiri; H Sakata; J Fujisaki; M Mizuguchi; N Fukushima; K Fujimoto
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Follicular lymphoma in Osaka, Japan: histological features and chronological change.

Authors:  Hajime Miyazato; Shin-ichi Nakatsuka; Itsuko Miyanaga; Hitoshi Hanamoto; Yoichi Tatsumi; Mitsuhiro Matsuda; Yasuhiro Maeda; Akihisa Kanamaru; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

3.  Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Authors:  Tiemo Katzenberger; German Ott; Thomas Klein; Jörg Kalla; Hans Konrad Müller-Hermelink; M Michaela Ott
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 4.  Clinical and molecular prognostic factors in follicular lymphoma.

Authors:  Andrew J Davies
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 5.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

6.  Follicular lymphoma grade 3B: is it a real disease?

Authors:  Nancy Lee Harris; Philip Kluin
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

7.  Follicular lymphoma with extensive gastrointestinal tract involvement: follow-up by capsule endoscopy.

Authors:  Boris Sapoznikov; Sarah Morgenstern; Pia Raanani; Adina Aviram; Esther Rabizadeh; Miron Prokocimer; Yaron Niv
Journal:  Dig Dis Sci       Date:  2007-03-13       Impact factor: 3.199

8.  S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.

Authors:  Roberto Chiarle; Yan Fan; Roberto Piva; Hugo Boggino; Jeffrey Skolnik; Domenico Novero; Giorgio Palestro; Chris De Wolf-Peeters; Marco Chilosi; Michele Pagano; Giorgio Inghirami
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

9.  Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.

Authors:  Mark A Samols; Nathan E Smith; Jonathan M Gerber; Milena Vuica-Ross; Christopher D Gocke; Kathleen H Burns; Michael J Borowitz; Toby C Cornish; Amy S Duffield
Journal:  Am J Clin Pathol       Date:  2013-10       Impact factor: 2.493

10.  A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.

Authors:  Andrew J Gentles; Ash A Alizadeh; Su-In Lee; June H Myklebust; Catherine M Shachaf; Babak Shahbaba; Ronald Levy; Daphne Koller; Sylvia K Plevritis
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.